https://www.globenewswire.com/news-release/20...ctors.html
MINNEAPOLIS, MN, US, Sept. 22, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV) (the “Company”), an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals, today announced the appointment of Jaime K. Pickett, DVM, MBA, to its Board of Directors, effective September 22, 2026.
“We are pleased to welcome Dr. Jaime Pickett to PetVivo’s Board of Directors,” said John Lai, Chief Executive Officer of PetVivo Holdings, Inc. “Jaime brings a valuable combination of veterinary expertise, executive leadership and experience growing veterinary care organizations. Her understanding of clinical practice, hospital operations and animal-health technology will provide an important perspective as we work to expand product adoption, strengthen relationships with veterinarians and pursue opportunities for sustainable growth.”
Dr. Pickett is a veterinary healthcare executive, entrepreneur and board leader with more than 20 years of experience in animal health, multi-site operations, corporate strategy, business development and product commercialization. She currently serves as Chief Medical Officer of EQUUSIR USA and as Advising Chief Medical Officer and a board member of Alexander International Innovations, providing clinical, regulatory, commercialization and strategic guidance for emerging medical and animal-health technologies. She also serves on the Board of Chief Veterinary Medical Officers and is a Scenthound multi-unit franchisee.
From 2023 to 2026, Dr. Pickett held executive leadership roles with Hannah Pet Hospitals, including Chief Executive Officer, President, board member and Chief Strategy Officer. From 2017 to 2022, she served as Chief Veterinary Officer and Senior Vice President of Pet Paradise and as Chief Operating Officer of its subsidiary, NewDay Veterinary Care. In these executive leadership roles, she led veterinary and operational strategy across more than 55 pet resorts and veterinary hospitals in over 15 states, directed teams of more than 100 veterinary professionals, and was instrumental to the organization’s strong enterprise revenue. Her experience also includes veterinary practice ownership, multi-site expansion, mergers and acquisitions evaluation, and telehealth implementation.
Dr. Pickett earned her Doctor of Veterinary Medicine from the University of Florida College of Veterinary Medicine, an MBA from St. George’s University and a Bachelor of Arts from Johns Hopkins University. She also completed the Global C-Suite Program through Wharton Executive Education at the University of Pennsylvania. She is a member of the American Veterinary Medical Association and served for nine years on the University of Florida College of Veterinary Medicine Admissions Committee.
“I am excited to join PetVivo’s Board and contribute both a veterinarian’s perspective and my experience building and leading animal-health businesses,” said Dr. Pickett. “Bringing new technologies into veterinary practice requires an understanding of clinical needs, practice operations and the support veterinary teams need to evaluate and adopt them. I look forward to working with John and the team to help advance PetVivo’s commercial strategy, strengthen connections with the veterinary community and create long-term value for shareholders.”
Dr. Pickett fills the vacancy created by Diane Levitan’s resignation, effective September 22, 2026. The Board thanks Dr. Levitan for her leadership, guidance and contributions during her tenure. Following these changes, the Board continues to consist of six directors.